Is eribulin treatment prognostic factor in patients with metastatic breast cancer treated with this drug? Retrospective analysis of a multicentre study.

CONCLUSIONS: Eribulin treatment line was identified as indepedent prognostic factor for PFS in MBC patients. PMID: 31786850 [PubMed - in process]
Source: Journal of B.U.ON. - Category: Cancer & Oncology Tags: J BUON Source Type: research